We are Fulfilling Unmet Needs in Pulmonary Medicine.
Aradigm is an emerging specialty pharmaceutical company developing
and commercializing a portfolio of drugs delivered by inhalation
for the treatment of severe respiratory disease.
Bolstered by its depth of expertise in pulmonary drug delivery
and an extensive intellectual property portfolio, the Company is
uniquely positioned to fulfill unmet needs in pulmonary medicine.
Our corporate strategy includes the following:
• Continued development of proprietary respiratory disease
• Pursue regulatory pathways that reduce the time,
costs and risks associated with product development
• Conservation of capital for proprietary product development
through the outsourcing of late stage clinical and commercial scale
• Deployment of a specialized sales and marketing force
to meet the unique needs of pulmonologists in the United States
• Out-licensing technology and intellectual property assets
for applications that lie outside the company's strategic interests
and core expertise